Should I buy EXEL stock?
EXEL Stock AnalysisEXEL is up 0.45% on 07/17/26 and has gained a total of 0.68% in the past 2 days.
EXEL is trading in the range of $50.75 - $57.57 in the past 30 days.
Bullish Indicators
Bearish Indicators
Neutral Indicators
| Technical Indicator | Value |
|---|
| 52 Week High | $57.10 | | 52 Week Low | $34.54 | | 200-Day Moving Average | 45.01 | | 50-Day Moving Average | 56.13 | | 20-Day Moving Average | 54.76 | | 10-Day Moving Average | 56.13 | | 5-Day Moving Average | 55.79 | | 28-Day Exponential Moving Average | 54.19 | | 22-Day Expontential Moving Average | 54.72 | | 12-Day Expontential Moving Average | 55.56 | | 9-Day Expontential Moving Average | 55.75 | | 5-Day Expontential Moving Average | 55.85 | | RSI (14) | 59.70 | | MACD | 1.2030 | | MACD Signal Line | 1.3481 | | MACD Histogram | -0.1451 | | ADX | 36.15 | | Upper Bollinger Band | 58.27 | | Lower Bollinger Band | 51.25 | | Average True Range (ATR) | 1.61 | | Accumulation/Distribution Line (ADL) | 68197369 | | Money Flow Index (MFI) | 49.44 | | Commodity Channel Index (CCI) | 43.37 | | Stochastic Oscillator | 67.73 | | Force Index | 127011.17 |
Short term rating on the EXEL stock: NEUTRAL with a score of 3/5.
Compare EXEL with any other stocks with the compare two stocks feature.
| Pivot Point Level |
Floor |
Woodie |
Camarilla |
DeMark |
Fibonacci |
| R4 |
|
|
|
|
|
| R3 |
|
|
|
|
|
| R2 |
|
|
|
|
|
| R1 |
|
|
|
|
|
| PP |
|
|
|
|
|
| S1 |
|
|
|
|
|
| S2 |
|
|
|
|
|
| S3 |
|
|
|
|
|
| S4 |
|
|
|
|
|
Biotechnology Stocks
Health Stocks
Technology Stocks
Cancer Stocks
Genentech Stocks
Medicine Stocks
Science Stocks
Therapeutic Stocks
Therapy Stocks
Gene Stocks
Lab Stocks
Mine Stocks
Tablet Stocks
Therapeutics Stocks
Atm Stocks
Commercialization Stocks
Multiple Stocks
Oncology Stocks
Pharma Stocks
Pharmaceuticals Stocks
Receptor Stocks
Research Stocks
Tech Stocks
Biotech Stocks
IoT Stocks
Stem Stocks
|